Pulse Biosciences Inc. has announced the issuance of inducement stock options to four newly hired employees, allowing them to purchase a total of 8,300 shares of company common stock. Approved by the independent Compensation Committee, these options are in line with Nasdaq Listing Rule 5635(c)(4) and are part of the company's 2017 Inducement Equity Incentive Plan. Each option has an exercise price of $17.13 per share, matching the closing price on May 19, 2025. The options will vest over four years, with a quarter of each award vesting annually, contingent on ongoing employment with Pulse Biosciences.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.